The pipeline is drawn as a straight line, but it behaves as a loop. A screen may return hits that are too weak, or optimization may reveal that a compound is toxic in cells, or preclinical testing may expose a safety problem. Each of those results sends the work back to an earlier stage, which is why lead optimization is described as iterative refinement rather than a single pass.
Can AI Run a Drug Discovery Lab on Its Own?